本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ovid Therapeutics Inc.

0.3236
+0.00842.66%
盤後0.33260.0090+2.78%19:31 EDT
成交量:24.64萬
成交額:7.98萬
市值:2,299.99萬
市盈率:-0.87
高:0.3295
開:0.3235
低:0.3145
收:0.3152
資料載入中...
2020/05/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/13

重要事件披露

Current report, items 7.01 and 9.01
2020/03/11

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/11

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

重要事件披露

Current report, items 8.01 and 9.01
2019/12/24

重要事件披露

Current report, item 5.02
2019/11/27

超過5%披露

[Amend] General statement of acquisition of beneficial ownership